Your browser doesn't support javascript.
loading
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Carrillo-Reixach, Juan; Torrens, Laura; Simon-Coma, Marina; Royo, Laura; Domingo-Sàbat, Montserrat; Abril-Fornaguera, Jordi; Akers, Nicholas; Sala, Margarita; Ragull, Sonia; Arnal, Magdalena; Villalmanzo, Núria; Cairo, Stefano; Villanueva, Alberto; Kappler, Roland; Garrido, Marta; Guerra, Laura; Sábado, Constantino; Guillén, Gabriela; Mallo, Mar; Piñeyro, David; Vázquez-Vitali, María; Kuchuk, Olga; Mateos, María Elena; Ramírez, Gema; Santamaría, Manuel López; Mozo, Yasmina; Soriano, Aroa; Grotzer, Michael; Branchereau, Sophie; de Andoin, Nagore García; López-Ibor, Blanca; López-Almaraz, Ricardo; Salinas, José Antonio; Torres, Bárbara; Hernández, Francisco; Uriz, José Javier; Fabre, Monique; Blanco, Julià; Paris, Claudia; Bajciová, Viera; Laureys, Geneviève; Masnou, Helena; Clos, Ariadna; Belendez, Cristina; Guettier, Catherine; Sumoy, Lauro; Planas, Ramón; Jordà, Mireia; Nonell, Lara; Czauderna, Piotr.
Afiliação
  • Carrillo-Reixach J; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain.
  • Torrens L; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de B
  • Simon-Coma M; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain.
  • Royo L; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain.
  • Domingo-Sàbat M; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain.
  • Abril-Fornaguera J; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de B
  • Akers N; Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School
  • Sala M; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain; Gastroenterology Department, Hospital Universitari Josep Trueta, Girona, Spain.
  • Ragull S; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain.
  • Arnal M; MARGenomics, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Villalmanzo N; PMPPC, IGTP, Badalona, Spain.
  • Cairo S; XenTech, Evry, France; Instituto di Ricerca Pediatrica, Corso Stati Uniti 4, Padova, Italy.
  • Villanueva A; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Kappler R; Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Lindwurmstr. 2a, 80337 Munich, Germany.
  • Garrido M; Hospital Vall d'Hebron, Pathology Department, Barcelona, Spain.
  • Guerra L; University Hospital La Paz, Pathology Department, Madrid, Spain.
  • Sábado C; Hospital Vall d'Hebron, Pediatric Oncology Department, Barcelona, Spain.
  • Guillén G; Hospital Vall d'Hebron, Pediatric Surgery Department, Barcelona, Spain.
  • Mallo M; MDS Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
  • Piñeyro D; High Content Genomics and Bioinformatics Unit, PMPPC, IGTP, Badalona, Spain.
  • Vázquez-Vitali M; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain.
  • Kuchuk O; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
  • Mateos ME; Pediatric Oncology Unit, Department of Pediatrics, University Hospital Reina Sofía, Córdoba, Spain.
  • Ramírez G; University Hospital Universitario Virgen del Rocío, Pediatric Oncology Department, Sevilla, Spain.
  • Santamaría ML; University Hospital La Paz, Pediatric Surgery Department, Madrid, Spain.
  • Mozo Y; University Hospital La Paz, Pediatric Oncology Department, Madrid, Spain.
  • Soriano A; Biomedical Research in Cancer Stem Cells Group, Pathology Department, Institut de Recerca Hospital Vall d'Hebron (VHIR), Barcelona, Spain.
  • Grotzer M; Department of Pediatric Oncology, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Branchereau S; Bicêtre Hospital, Le Kremlin-Bicêtre, France.
  • de Andoin NG; Pediatric Oncology, Hospital Universitario Donostia, Doctor Begiristain Kalea, 117, 20080, Donostia, Spain.
  • López-Ibor B; Department of Pediatric Hematology and Oncology, HM Montepríncipe Hospital, Boadilla del Monte, Madrid, Spain.
  • López-Almaraz R; Pediatric Oncology and Hematology, Hospital Universitario Cruces, Bilbao, Spain.
  • Salinas JA; Division of Hematology-Oncology, Department of Pediatrics, Hospital Universitari Son Espases, Palma de Mallorca, Spain.
  • Torres B; Medical Oncology Department, Pediatric Oncology Department, University Hospital La Fe, Valencia, Spain.
  • Hernández F; University Hospital La Paz, Pediatric Surgery Department, Madrid, Spain.
  • Uriz JJ; Pediatric Oncology, Hospital Universitario Donostia, Doctor Begiristain Kalea, 117, 20080, Donostia, Spain.
  • Fabre M; Department of Pathology, Hôpital Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, and Université Paris Descartes, Paris, France.
  • Blanco J; IrsiCaixa AIDS Research Institute, IGTP, Badalona, Catalonia, Spain; University of Vic - Central University of Catalonia, Vic, Spain.
  • Paris C; Stem Cell Transplant Unit, Hospital Luis Calvo Mackenna, Santiago, Chile.
  • Bajciová V; Department of Pediatric Oncology, Childrens University Hospital Brno, Brno, Czech.
  • Laureys G; Department of Pediatric Hematology, Oncology and Hematopoietic Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
  • Masnou H; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain.
  • Clos A; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain.
  • Belendez C; Oncohematology Service, Hospital Gregorio Marañón, Madrid, Spain.
  • Guettier C; Bicêtre Hospital, Le Kremlin-Bicêtre, France.
  • Sumoy L; High Content Genomics and Bioinformatics Unit, PMPPC, IGTP, Badalona, Spain.
  • Planas R; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain.
  • Jordà M; PMPPC, IGTP, Badalona, Spain; Consortium for the Study of Thyroid Cancer, CECaT, Barcelona, Spain.
  • Nonell L; MARGenomics, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Czauderna P; Department of Surgery and Urology for Children and Adolescents, Medical University of Gdansk, Gdansk, Poland.
J Hepatol ; 73(2): 328-341, 2020 08.
Article em En | MEDLINE | ID: mdl-32240714

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colina Quinase / Hepatoblastoma / Beta Catenina / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colina Quinase / Hepatoblastoma / Beta Catenina / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha